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SUMMARY
Seventy cases of pulmonary carcinoma, consisting of 20 cases of squamous cell carcinoma,
22 cases of adenocarcinoma and 28 cases of small cell carcinoma, were examined immunohisto-
chemically using the peroxidase anti-peroxidase method, and antisera raised against carcinoem-
bryonic antigen, keratin, neuron specific enolase, Leu-7, beta-2 microglobulin.
The immunoreactivity of NSE, and of Leu-7 were very different among oat cells, inter-
mediate cells, and combined subtypes of small cell lung cancer, while Leu-7 was rarely seen in
adenocarcinoma or squamous cell carcinoma. Keratin was demonstrated not only in non-small
cell lung cancer but also in intermediate and combined types of small cell lung cancer.
These results seems to support the "Y" concept which describes the relationship between non-
small cell lung cancer and small cell lung cancer.
Besides the WHO classification of 1981, which divides the small cell lung cancer into oat
cell, intermediate and combined subtype, the usefulness of a tentative classification of International
Association for Study of Lung Cancer (IASLC) which divides them into classic (pure), variant,
and combined type was discussed.
INTRODUCTION
For several years, there has been much discussion on the histogenesis, clinical and biological
entity of small cell lung cancer (SCLC), and their concepts have undergone major changes.
Many investigators including medical and surgical oncologists as well as pathologists are recently
concerned about its histological classification, because; 1) the small cell carcinomas comprise
15-25 percent of the lung cancers. 2) Tumors metastasize early and even "limited" disease
cases have latent metastases. 3) Cure by local treatment as surgical resection or conventional
radiotherapy is difficult, and prognosis is poor (3). 4) The lesion is highly sensitive to many
chemotherapeutic agents. Thus, with progress in chemotherapy, improvement of survival and
cure rate can be expected in future. 5) Despite its very simple histological structure, its
ultrastructure is characterized by the presence of granules analogous to neuroendocrine granules as
well as possible differentiation into epithelial cells (4); and 6) biochemically, it shows high
activities of L-dopa-decarboxylase, neuron specific enolase and creatinine kinase BB, and poly-
peptide hormone production, which are characteristic of nerve, neuroendocrine cells, and APUD
cells. (5-9)
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Many investigations have been made on the histological classification of pulmonary carcinoma
using morphological, biological, biochemical and immunohistochemical techniques to establish a
further comparative classification that may aid us in predicting the behavior of the tumors and
guide the clinician in selecting the most appropriate treatment.
We employed an immunohistochemical technique to investigate the characteristics of the
subtypes of SCLC, using the following tumor markers in the cancer cells.
Carcinoembryonic antigen (CEA), one of the most widely studied tumor markers, is detected
in the fetal colon during the third trimester of pregnancy. It is found in tissues derived from
endoderm, but subsequently has been associated with neoplasms arising from mesoderm and
ectoderm. (10) CEA localizes on the tumor cell surface membrane~ suggesting that CEA is a
peripheral membrane glycoprotein. (11)
Keratin is an epidermal protein which has been shown to localize ultrastructurally to
epidermal tonofilaments and is often noted in: intimate association with desmosomes. (12)(13)
It is present within the basal cells and intermediate cells of the normal trachea, bronchus and in
the ducts of the bronchial glands. (14)
Neuron specific enolase (NS E) is a glycolytic enzyme, present in the cytoplasm of the
neuroendocine cell. It was first reported as a valuable tumor marker of SCLC in 1982 by
Carney. (15) Recently, SCLC has been found to contain NSE, which exhibits neuroendocrine
properties. (16)
Anti Leu-7 antibody was initially found to react with natural killer cells (NK cell), and
subsequently with myelinated nerves of the peripheral system and central nervous system. (17)
Leu-7 is also a marker of neuroendocrine properties of SCLC. (18)
Beta-2 microglobulin (Beta-2 M) is a component of transplantation antigens present in the
surface membrane of mammalian cells. Recently, Beta-2 M has been suggested to be associated
with tumor specific antigens suggested to be modified transplantation antigens. It has been
found to be structurally related to immunoglobulin G and to the common portion fragment of
HL-antigen molecules and produced by a variety of nucleated cells. The Beta-2 M concentration
is fully related to the stage of differentiation of the tumors, the most differentiated tumors con-
tain the highest concentration of Beta-2 M, and poorly differentiated tumors contain a lower
concentration. (21)
In this report we tried to clarify the difference in subtypes of small cell lung cancer by an
immunohistology of some tumor markers.
MATERIALS AND METHODS
Histological section of 70 cases of pulmonary carcinoma were obtained from surgical speci-
mens. Twenty eight small cell carcinoma, including 8 cases of oat cell subtype, 16 intermediate
subtype, and 4 combined subtype, 22 adenocarcinoma, 20 squamous cell carcinoma were investi-
gated after the histological study, according to the World Health Organization (WHO) classifi-
cation. (Table-I) (20)
The immunohistochemical technique was performed on 5 J1-m thick paraffin-embedded sections
using the immunoperoxidase method (peroxidase anti-peroxidase). (1)
Sections were sequentially incubated for 30 minutes at room temperature with each of the
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following reagents: 1. Methanolic hydrogen peroxide. 2. Non-specific background staining was
minimized by using normal swine serum (1: 20) for 30 minutes following methanolic peroxide
treatment. 3. Rabbit anti-human CEA, Beta-2 M, keratin (DAKO INC. DENMARK), NSE
(DAKO PAP kit), anti Leu-7 antibody (Becton Dickinson Inc.). 4. Swine anti-rabbit serum
IgG. (1: 20. DAKO). Demonstration of Leu-7 was performed by the ABC kit. (Vector Lab,
Inc.) 5. Horseradish peroxidase-rabbit anti-horseradish peroxidase soluble complexes. (1 :50.
DAKO).
This buffer (0. 1 M PH : 7. 6) was used for all dilutions. Following each incubation, slides
were washed thoroughly with this buffer (0. 1 M PH: 7.6) for 20 minutes.
Antigen localization was determined on the basis of peroxidase activity, stained by a 5
minute incubation of the sections with a freshly prepared solution containing 3, 3'diaminobenzidine
tetrahydrochloride, (Nakarai Chemical Ltd.) and hydrogen peroxide. Slides were washed with
water, counterstained with Meyer's hematoxylin, dehydrated and mounted in Permount.
Normal rabbit serum or normal mouse serum was used as a control.
RESULTS
Table 2 summanzes the results of immunohistochemical studies m vanous human lung
cancers.
The CEA immunoreactivity was detected in 5 of the 8 cases of the oat cell subtype, 12 of the
16 cases of the intermediate subtype, 3 of the 4 cases of combined subtype of SCLC (Fig-I),
16 of the 22 cases of adenocarcinoma, and 12 of the 20 cases of squamous cell carcinoma,
although the intensity of staining ranged from weak to strong. (Fig-2) Thus, there was no
significant difference in the positive rate of CEA among squamous cell carcinoma, adenocarcinoma
and small cell carcinoma of lung.
Many of the intermediate type cases of small cell carcinoma were positive for keratin
Table 2. Results of the immunohistochemical studies on pulmonary carcinomas.
according to WHO classification
CEA. Keratin. NSE. Leu-7. Beta-2 M.
----_~._---.. _- _~~~~_---
Small cell carcinoma.
Oat cell type. 62.5% 0% 75% 62.5% 0%
Intermediate subtype. 75% 81. 2% 81.2% 68.7% 6.2%
Combined subtype. 75% 75% 25% 50% 0%
Adenocarcinoma. 73% 77% 59% 18% 50%
Squamous cell carcinoma. 60% 85% 35% 0% 40%
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Fig. 1. Combined subtype of SCLC stained for CEA by the immunoperoxidase method. Note
the positive staining on tumor cell surface membrane. (X2000)
Fig. 2. Squamous cell carcinoma of lung. Strong staining for intracellular CEA is observed in
tumor cells. (X2000)
Fig. 3. Immunoperoxidase positivities of keratin in intermediate subtype of SCLC. But not in oat
cell type. (X2000)
Fig. 4. Oat cell subtype of SCLC stained for NSE by the immunoperoxidase method. Note the
marked cytoplasmic staining of tumor cells. (X200)
Fig. 5, Oat cell subtype of SCLC stained for Leu-7 by the immunoperoxidase method. Positive
staining is observed in many tumor cells. (X200)
Fig. 6. Adenocarcinoma of lung stained for Beta-2 M by the immunoperoxidase method. Positive
staining is observed in most differentiated tumor cells, but negative in small cell
carcinoma of lung. (X200)
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(Fig-3), but, none of the oat cell subtype cases were. Furthermore, keratin was demonstrated
frequently in the combined subtype. Strongly positive staining was observed in the squamous
cell carcinoma and adenocarcinoma cells.
In our study, NSE immunoreactivity was present in a high percentage of the oat cell and
intermediate subtype cells (Fig-4), but in only 1 of the 4 cases of the combined subtype. NSE
was demonstrated in 35% of the squamous cell carcinomas and 59% of the adenocarcinomas.
Squamous cell carcinomas were negative for Leu-7, and only 4 of the 22 adenocarcinomas
were positive for Leu-7. However, 5 of the 8 oat cell subtype cases, 11 of the 16 intermediate
subtype cases, and 2 of the 4 combined subtype cases of the SCLC were positive for Leu~7
(Fig-5), which was focally positive in small clusters or in occasional solitary cells. This pattern
of reactivity was similar to the immunohistological findings of NSE.
In contrast, 27 of the 28 cases of the small cell carcinoma were non-reactive with anti-Beta-2
M, but 11 of the 22 cases in adenocarcinoma, and 8 of the 20 cases in squamous cell carcinoma
were positive. (Fig-6)
DISCUSSION
SCLC has been thought to be an APUDoma of the lung derived from Kultschitzky cells
of the bronchus, and differs from other types of lung cancers. This hypothesis was proposed by
Pearse in 1971, (2) and has been supported by a number of investigators. (24) Because of its
rapid growth and high sensitivity to chemotherapy, SCLC has generally been considered an
"undifferentiated tumor." However, this concept has been re-examined because some findings
have indicated that SCLS is derived from the same pulmonary endodermal precursor as other
lung cancers and differs only in its degree and direction of differentiation. (25)
Detailed examination revealed that approximately 6% of the SCLC contained components
of NSCLC, and patients with the initial diagnosis of SCLC showed the coexistence of other
histological types or a complete change to the diagnosis of NSCLC, at autopsy. (26)
Electron-microscopically, some SCLC contain cytoskeletal components such as tonofilaments and
desmosomes in the cytoplasm. (27)
The SCLC cell line transforms into a NSCLC cell line (mainly into large cell carcinoma)
during serial passage, losing the APUD features; and slight enzyme activities indicative of the
APUD features are observed in adenocarcinoma and squamous cell carcinoma. In addition,
SCLC cell lines and xenografts almost always express the findings of the intermediate subtype
and this subtype has been postulated to be the true morphological expression of SCLC while
the oat cell subtype probably represents a degenerative form or artifact. (33) (35) Cell culture
studies indicated that SCLC cell lines can be divided into three distinct subclasses: Classic
cell lines had morphological features of the intermediate subtype of SCLC, expressing the entire
range of SCLC biochemical feature. Variant cell lines could further be divided into two subclasses:
SCLC biochemical variant cell lines (SCLC-BV) and SCLC morphological variant cell lines
(SCLC-MV). SCLC-MV cell lines and their xenografts had some or all of the morphological
features of large cell undifferentiated carcinoma. (28) These findings led Gazdar et al. to
support the "unitarian theory" of the histogenesis proposed by Yesner and Carter in 1982. (29)
This unitarian theory explains the mixture of NSCLC in the tumor tissue of SCLC and
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transformation of SCLC into NSCLC during the therapeutic course in some cases. Therefore,
SCLC and NSCLC can be of "common stem cell origin" and SCLC is a tumor that has
undergone a "neuroendocrine programmed" differentiation. (30)
According to the WHO histological classification of SCLC, (Table-I), the polygonal and
fusiform variants are classified as an intermediate type and a new combined type category was
introduced to put the SCLC together with other histologic types. Recently, some studies have
suggested that the various SCLC subtypes have different responses to therapy or survival, (31)
but others found no significant difference in the clinical behavior, response to therapy or survival
among these subtypes. (32) By light microscopy, the oat cell carcinomas are characterized by
uniform small cells with a very sparse cytoplasm, the intermediate type of small cell carcinoma is
very similar to the oat cell type, but in some cells the cytoplasm is more abundant, and epidermoid
differentiation is not discernible at the light microscopic level. Almost 10% of the SCLC are
difficult to interprete by light microscopy particularly when the tumors are undergoing transition
to large cell carcinoma and they have squamous cell differentiation and/or glandular components.
It is important that the small cell elements of these tumors be recognized for appropriate
classification. (33) (34) In our studies the keratin positive rate was high in the non-oat cell
type, whereas, keratin was not demonstrated at all in the oat cell type. Thus, the concentration
of keratin seems to be useful to distinguish oat cell type from intermediate cell type. As
mentioned above, however, the question is whether the WHO classification of 1981 is not
practical use, because this classification does not reflect the clinical feature.
Recently, a new tentative classification was introduced: classic (pure), variant, and com-
bined subtypes, according to morphological feature, and histogenetical characterizations which
manifested on the immunohistochemical profile. (22)
When observed by this classification there was no difference with CEA immunoreactivity
among the three SCLC subtypes. (Table-3) Classic cell types retained higher concentration of
NSE and Leu-7, but had significantly lower concentrations of Beta-2 M. Keratin was found
in 43. 7% of classic cell types. The variant cell types of SCLC presented almost higher reactivities
with CEA, NSE, keratin and Leu-7. However Beta-2 M was also negatively stained in the classic
type. This suggests that the variant type cell shows an epidermoid differentiation as does
squamous cell carcinoma, although tumor combinations of SCLC with squamous cell carcinoma
or adenocarcinoma are classified as "combined SCLC" which present a weakly positive immuno-
reaction with NSE and Leu-7.
The fact that keratin was found in 43.7% of classic cell subtype but in none of oat cell
subtype, suggest that the WHO classification is more practical than the new tentative classifi-
cation from the biological point of view, and that SCLC seems to be differentiated from
Table 3. Results of the immunohistochemical studies on small cell lung
cancer according to tentative classification of IASLC
CEA Keratin NSE. Leu-7. Bete-2 M.
pure subtype (classic). 62.5% 43.7% 87.5% 75% 0%
variant subtype. 87.5% 75% 62.5% 50% 12.5%
combined subtype. 75% 75% 25% 50% 0%
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"common stem cell" as NSCLC, and also seems to support the "Y" concept (29) which describes
the relationship between SCLC and NSCLC. We expect this "unitarian theory" on the
histogenesis of lung cancer may be more consistent and useful III subclassifying the SCLC.
Further biological and morphological investigation is necessary to study the more adequate
classification of SCLC in future.
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